Amneal Pharmaceuticals, Inc. (AMRX)

Pharmaceutical Preparations

Latest Price

$20.14

TTM P/E

41.96

Normalized P/E

Div Yield

Book Value

0.10

P/B Ratio

194.59

Valuation metrics

EPS: $0.22

Target P/E: 42×

Formula: EPS × P/E

P/E Fair Value

$9.24

54% downside

51.1% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	26.56M	$459.0M	8.32%	+2.04M	2026-06-30
Tpg GP A, LLC	12.33M	$213.0M	3.86%	--	2026-06-30
Vanguard Portfolio Management LLC	12.14M	$210.0M	3.80%	+812.8K	2026-06-30
Rubric Capital Management LP	10.17M	$176.0M	3.19%	-868.9K	2026-06-30
Vanguard Capital Management LLC	7.71M	$133.0M	2.42%	+125.1K	2026-06-30
State Street Corp	7.36M	$127.0M	2.30%	+562.3K	2026-06-30
Dimensional Fund Advisors LP	5.79M	$100.0M	1.82%	+103.7K	2026-06-30
Geode Capital Management, LLC	5.14M	$88.0M	1.61%	+593.4K	2026-06-30
Morgan Stanley	4.11M	$71.0M	1.29%	-527.2K	2026-06-30
Neuberger Berman Group LLC	3.89M	$67.0M	1.22%	+204.9K	2026-06-30